Sex: M
Vaccine: SMALLMNK
Symptoms: Expired product administered, Inappropriate schedule of product administration, No adverse event
Clinical narrative: second dose of Jynneos administrated intradermally; The vial was opened yesterday and was administered today.; second dose of Jynneos administered 42 days after the first dose; Case reference number US-BN-2022-004012 is a spontaneous case report initially received on 11-Oct-2022 from a nurse via Agency (reference number: USBAV22-1680) and concerns a 36-year-old male patient.  The patient's medical history and concomitant medications details were not provided.  On 30-Aug-2022, the patient was vaccinated with a first dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: unknown) at an unknown dose, administered subcutaneously (SC), at unknown anatomical location, for monkeypox (smallpox) prophylaxis.  On 11-Oct-2022, 42 days after the first dose, the patient was vaccinated with a second dose of Jynneos vaccine (smallpox and monkeypox vaccine, live, nonreplicating; batch number: FPD00005), (explicitly coded as 'inappropriate schedule of vaccine administrated'), at an unknown dose, administered intradermally (ID), (explicitly coded as 'intradermal injection'), at unknown anatomical location, for monkeypox (smallpox) prophylaxis.  The nurse reported that the patient received the second dose that was beyond use date (explicitly coded as 'expired product administered'). As reported, the vial was opened yesterday and was administered today.  At the time of this report, it was unknown if the patient experienced any adverse event.  Additional information received on 11-Oct-2022 from Bavarian Nordic included local BN case ID.  No further information was provided.; Reporter's Comments: A 36-year-old male patient was vaccinated with a second dose of Jynneos vaccine 42 days after the first dose, administered intradermally for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. The nurse reported that the patient received the second dose that was beyond use date. No associated adverse events were reported. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are listed per company convention. The patient's medical history and concomitant medications details were not provided. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are not related to Jynneos, but to a human factor. The case is non-serious.; Sender's Comments: A 36-year-old male patient was vaccinated with a second dose of Jynneos vaccine 42 days after the first dose, administered intradermally for monkeypox prophylaxis which is considered as inappropriate schedule of vaccine administered. The nurse reported that the patient received the second dose that was beyond use date. No associated adverse events were reported. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are listed per company convention. The patient's medical history and concomitant medications details were not provided. Intradermal injection, inappropriate schedule of vaccine administered, and expired product administered are not related to Jynneos, but to a human factor. The case is non-serious.